TruStem Cell Therapy™ for Multiple Sclerosis
Numbness or tingling sensations
Acute or chronic pain
Difficultly talking or swallowing
Visual disturbances (such as double vision)
Bladder and bowel issues
What is Multiple Sclerosis?
Multiple sclerosis (MS) is a chronic, progressive neurological disease in which specific patterns of damage, often referred to as lesions, form in the brain and spinal cord. MS is considered to be an autoimmune disorder or a condition in which the body’s immune system attacks, damages, and/or kills cells within the central nervous system (CNS). The result of this damage is a myriad of symptoms and complications that severely reduces an individual’s quality of life.
There are four types of Multiple Sclerosis:
is the most common type of MS where attacks come and go over time and there is no apparent progression of the disease
Secondary progressive (SPMS)
follows the relapsing remitting course and eventually gets progresses more steadily.
Primary progressive (PPMS)
occurs when the disease progressively gets more advanced over time without going through a relapsing remitting course.
Progressive relapsing MS (PRMS)
is characterized by steadily progressing disease from the beginning and occasional exacerbations along the way.
What causes Multiple Sclerosis?
What type of stem cells are used and why?
TruStem Cell Therapy provides access to treatment that utilizes a patient’s stem cells isolated from their own bone marrow. There are multiple inherent benefits afforded by the utilization of bone marrow derived stem cells as Bone marrow (BM) and bone marrow components function in various diverse, innate therapeutic capacities.
Hematopoietic stem cells (HSCs), found within BM, are the body’s source of most cells found in the peripheral or circulating blood. These include red blood cells and white blood cells (such as monocytes). In addition to HSCs, mesenchymal stem cells (MSCs) are also contained within BM. Evidence suggests MSCs can enter the circulating blood during injury and have been shown to readily home to areas of injury or inflammation. Once at these damaged tissue sites, MSCs can exert both protective cellular and immunomodulatory effects believed to be critical in many neurological and auto-immune conditions.
What steps are involved in receiving treatment through TruStem Cell Therapy?
How are stem cells administered back into Multiple Sclerosis patients through TruStem Cell Therapy?
Multiple Sclerosis patients who receive stem cell therapy through us can receive multiple systemic and targeted administration methods:
Systemic IV infusion of their stem cells to fully saturate the entire body.
Intranasal administration to target the myelin sheath of the neurons
Bladder catheterization to improve incontinence in patients
Localized injections into atrophied muscles
What is unique about receiving stem cell therapy through TruStem Cell Therapy for Multiple Sclerosis?
Our focus is safety, efficacy, and patient-centric care when providing access to superior stem cell therapy.
We utilize only board certified surgeons, physicians and accredited clinicians to provide care for patients.
Laboratory protocols are developed and refined by our PhD Neuroscientist.
A clinical team with expertise in practicing cellular based medicine.
Accredited Surgical Centers for enhanced procedural and patient safety
Targeted administration methods that direct stem cells toward specific
areas of injury which include the joints, brain, spine, lungs, etc…
Skilled Patient Advocates who are trained to provide truthful, realistic expectations resulting from stem cell therapy.
Can this treatment cure Multiple Sclerosis?
It is important for patients and caregivers to understand that current therapies, including stem cell treatment, does not provide a cure for MS. However, TruStem Cell Therapy may have the potential to improve a patient’s quality of life by reducing symptoms and complications related to MS as well as slowing its progression.